Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer

Clinical trial NCT06865521 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06865521
Sponsor: West China Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Colo-rectal Cancer PD-1 Inhibitor Akkermansia Muciniphila

Start date: 2025-02-21
Primary completion: 2025-07-10
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.